MedPath

Clinical effect of Naoxue oral liquid on patients with spontaneous cerebral hemorrhage: a single-center, open, non-randomized controlled study

Phase 4
Conditions
spontaneous intracerebral hemorrhage
Registration Number
ITMCTR2100005320
Lead Sponsor
orth China University of Science and Technology Affiliated Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

inclusion criteria:
1. Patients who were confirmed by magnetic resonance imaging ((MRI)) and computerized tomography ((CT)) and met the criteria for the diagnosis and treatment of SICH approved in the AHA/ASA guidelines were selected.
2.the amount of supratentorial bleeding = 30ml, the displacement of midline does not exceed 5mm, and the amount of subependental bleeding = 10ml.
3. The age is between 18 and 80 years old.
4. Select SICH patients within one week of onset
5. The NIHSS score is between 2 and 20.
6. Obtain the informed consent of the patient.

Exclusion Criteria

1.the amount of supratentorial bleeding > 30ml, the shift of midline exceeded 5mm, and the amount of subependental bleeding > 10ml.
2. Severe dysarthria, hearing impairment, cognitive impairment and other reasons lead to the inability of patients to cooperate with the scale assessment.
two
3. Patients with loss of consciousness and disturbance of consciousness
4. Because of the insufficiency of important organs such as heart, liver and kidney, the researchers do not think it is suitable to participate in this study.
5. A person with a serious mental illness.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serious adverse events;Severity of brain edema;Volume of hematomas;
Secondary Outcome Measures
NameTimeMethod
iver function;Blood routine;Coagulation function;Neural function evaluation;Renal function;
© Copyright 2025. All Rights Reserved by MedPath